论文部分内容阅读
目的:分析肝硬化疾病诊断中生化检验项目的应用价值。方法:选取2016年9月-2017年4月我院收治的肝硬化患者73例作为研究对象,记为实验组,同时选取73例正常人作为对照组,对比两组的生化检验指标和纤维化指标。结果:实验组患者的天冬氨酸氨基转移酶、胆红素和纤维化指标均高于对照组,白蛋白和白蛋白与球蛋白比值则低于对照组,P<0.05,差异具有统计学意义。结论:通过检验生化项目能够快速发现肝硬化患者的肝功能受损程度和肝脏代谢功能异常情况,可以作为肝硬化疾病诊断的临床依据,让患者尽早接受治疗,缩短治疗时间,可以推广应用。
Objective: To analyze the value of biochemical tests in the diagnosis of cirrhosis. Methods: Seventy-three patients with cirrhosis who were admitted to our hospital from September 2016 to April 2017 were selected as the experimental group and 73 normal subjects were selected as the control group. The biochemical indexes and fibrosis index. Results: The aspartate aminotransferase, bilirubin and fibrosis indexes in the experimental group were higher than those in the control group, while the ratios of albumin, albumin and globulin were lower than those in the control group, P <0.05, the difference was statistically significant significance. Conclusion: The liver damage and hepatic metabolism dysfunction in patients with cirrhosis can be quickly detected through the biochemical test. It can be used as a clinical basis for the diagnosis of cirrhosis. Patients can be treated as soon as possible and the treatment time can be shortened.